|
(ÁÖ) ¸Þµð½Ã½º(MediSys) |
ÇǺΰú ¼ºÇü¿Ü°ú ÀÇ·áÀåºñ ´ë¸®Á¡ ¹× µô·¯ ¸ðÁýÇÕ´Ï´Ù.
Àü±¹ Àü±¹ | ´ëÇÐ(2~3³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
»ó½Ãä¿ë |
01.19 |
|
|
(ÁÖ)Å´½ºÁ¦¾à |
Å´½ºÁ¦¾à µô·¯ ¹× ÇÁ¸®·£¼ ¸ðÁýÇÕ´Ï´Ù
Àü±¹ ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
»ó½Ãä¿ë |
01.02 |
|
|
(ÁÖ)À¯Áø¸ÞµðÄɾî |
Á¤Çü¿Ü°ú ÀÇ·á±â±â ¿µ¾÷»ç¿ø ¸ðÁý
¼¿ï ¼ºµ¿±¸ | °íµîÇб³ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
09.24 |
|
|
(ÁÖ)´ë¾ÈÀÇ·á±â |
ôÃß°ßÀÎÀÇ·á±â ¿µ¾÷»ç¿ø¸ðÁý
¼¿ï ±¤Áø±¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
11.19 |
|
|
À̳ëºê·¹ÀÎ |
Senior Quality Standards Associate Ãʺù
¼¿ï °ºÏ±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
12.07 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Feasibility - Site ID Specialist
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
SSU |
2³â¡è |
ä¿ë½Ã |
07.21 |
|
|
¸®¸¶ÄÚ¸®¾Æ(Lima Korea) |
<¿Ü±¹°èÁö»ç> Lima Korea ¿µ¾÷ °æ·ÂÁ÷ ¸ðÁý(Àΰø°üÀý, 2³â~5
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
08.29 |
|
|
(ÁÖ)¹ÙÀÌ¿ÀÁö³ëÄÚ¸®¾Æ |
±â¾÷ºÎ¼³¿¬±¸¼Ò NGS»ç¾÷ºÎ À¯ÀüüºÐ¼® ¿¬±¸¿ø, ¼±ÀÓ¿¬±¸¿ø
¼¿ï ¼ºµ¿±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
2³â¡è |
ä¿ë½Ã |
07.30 |
|
|
ICON Clinical Research Korea |
Jr. Clinical Research Associate(Oncology)
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.22 |
|
|
(ÁÖ)¿¡ÀÌÁ§ÄÚ¸®¾Æ |
[¿Ü±¹°è] ÀÇ·á±â±â Ç°Áú°ü¸®ºÎ QA/RA »ç¿ø ¸ðÁý
¼¿ï ÀüÁö¿ª, ¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
2³â¡è |
ä¿ë½Ã |
08.26 |
|
|
µå¸²¼Ö·ç¼Ç |
»óÀå»ç ÀÇ·á±â±â ¿¬±¸¼Ò Analog HW,µðÁöÅ» H/W,½Åȣó¸®,¿µ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
°³¹ß/RA/´ë°ü |
2³â¡è |
ä¿ë½Ã |
03.06 |
|
|
PSI CRO Korea |
[PSI CRO Korea] SSU Associate
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
SSU |
2³â¡è |
ä¿ë½Ã |
05.04 |
|
|
(ÁÖ)Á¤ÁøÆÊ |
(ÁÖ)Á¤ÁøÆÊ ÇϹݱ⠺´¿ø¿µ¾÷»ç¿ø ä¿ë °ø°í
¼¿ï ±¸·Î±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
10.22 |
|
|
(ÁÖ)º§¸óÆ®¸®½áÄ¡ |
(ÁÖ)º§¸óÆ®¸®½áÄ¡ ½ÅÀÔ / °æ·Â CRA ¸ðÁý
¼¿ï ¼ºµ¿±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
10.24 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
05.04 |
|